Notably, the abundance of CD70- and CD73-expressing CAFs was significantly associated with a worse prognosis in CRC patients [138,140,141], thereby emphasizing the involvement of immunomodulatory CAFs in CRC progression. Here, NT5E is linked to colorectal carcinoma.